Operating Expenses Summary of Novartis AG

Novartis AG's latest annual operating expenses in 2023 was 24.41 Billion USD , down -10.04% from previous year.
Novartis AG's latest quarterly operating expenses in 2024 Q1 was 5.65 Billion USD , down -8.44% from previous quarter.
Novartis AG reported a annual operating expenses of 27.14 Billion USD in annual operating expenses 2022, up 7.2% from previous year.
Novartis AG reported a annual operating expenses of 25.32 Billion USD in annual operating expenses 2021, up 2.83% from previous year.
Novartis AG reported a quarterly operating expenses of 5.65 Billion USD for 2024 Q1, down -8.44% from previous quarter.
Novartis AG reported a quarterly operating expenses of 6.31 Billion USD for 2024 Q3, up 11.01% from previous quarter.

Annual Operating Expenses Chart of Novartis AG (2023 - 1998)

Historical Annual Operating Expenses of Novartis AG (2023 - 1998)

Year	Operating Expenses	Operating Expenses Growth
2023	24.41 Billion USD	-10.04%
2022	27.14 Billion USD	7.2%
2021	25.32 Billion USD	2.83%
2020	24.62 Billion USD	-2.15%
2019	25.16 Billion USD	-5.36%
2018	26.59 Billion USD	9.28%
2017	24.33 Billion USD	2.89%
2016	23.64 Billion USD	-1.49%
2015	24 Billion USD	-4.74%
2014	25.2 Billion USD	-10.99%
2013	28.31 Billion USD	3.73%
2012	27.29 Billion USD	-7.14%
2011	29.39 Billion USD	15.06%
2010	25.54 Billion USD	11.35%
2009	22.94 Billion USD	3.43%
2008	22.18 Billion USD	4.95%
2007	21.13 Billion USD	14.23%
2006	18.5 Billion USD	10.43%
2005	16.75 Billion USD	11.07%
2004	15.08 Billion USD	15.3%
2003	13.08 Billion USD	8.32%
2002	12.07 Billion USD	18.58%
2001	10.18 Billion USD	-5.54%
2000	10.78 Billion USD	1.99%
1999	10.57 Billion USD	1.76%
1998	10.38 Billion USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	5.68 Billion USD	0.6%
2024 Q1	5.65 Billion USD	-8.44%
2024 Q3	6.31 Billion USD	11.01%
2023 FY	24.41 Billion USD	-10.04%
2023 Q2	6.67 Billion USD	3.96%
2023 Q1	6.42 Billion USD	-9.12%
2023 Q3	7.21 Billion USD	8.06%
2023 Q4	6.17 Billion USD	-14.43%
2022 Q2	7.1 Billion USD	16.38%
2022 Q3	6.86 Billion USD	-3.35%
2022 Q4	7.06 Billion USD	2.87%
2022 FY	27.14 Billion USD	7.2%
2022 Q1	6.1 Billion USD	-12.57%
2021 Q2	5.9 Billion USD	-5.43%
2021 Q3	6.19 Billion USD	5.0%
2021 Q4	6.98 Billion USD	12.72%
2021 FY	25.32 Billion USD	2.83%
2021 Q1	6.24 Billion USD	1.15%
2020 FY	24.62 Billion USD	-2.15%
2020 Q2	5.84 Billion USD	-6.42%
2020 Q1	6.24 Billion USD	-9.55%
2020 Q3	6.37 Billion USD	9.11%
2020 Q4	6.16 Billion USD	-3.2%
2019 Q2	5.95 Billion USD	-0.12%
2019 Q3	6.34 Billion USD	6.6%
2019 FY	25.16 Billion USD	-5.36%
2019 Q4	6.9 Billion USD	8.71%
2019 Q1	5.96 Billion USD	-19.85%
2018 Q1	6.12 Billion USD	-7.24%
2018 Q3	5.68 Billion USD	-12.43%
2018 FY	26.59 Billion USD	9.28%
2018 Q4	7.43 Billion USD	30.88%
2018 Q2	6.49 Billion USD	5.94%
2017 Q2	5.95 Billion USD	3.44%
2017 FY	24.33 Billion USD	2.89%
2017 Q4	6.6 Billion USD	9.86%
2017 Q3	6.01 Billion USD	0.94%
2017 Q1	5.75 Billion USD	-13.57%
2016 Q4	6.66 Billion USD	16.8%
2016 FY	23.64 Billion USD	-1.49%
2016 Q1	5.14 Billion USD	-21.75%
2016 Q2	6.13 Billion USD	19.2%
2016 Q3	5.7 Billion USD	-7.03%
2015 Q4	6.57 Billion USD	12.2%
2015 Q2	6.12 Billion USD	12.71%
2015 Q1	5.43 Billion USD	-17.46%
2015 FY	24 Billion USD	-4.74%
2015 Q3	5.86 Billion USD	-4.32%
2014 Q2	6.38 Billion USD	5.97%
2014 Q1	6.02 Billion USD	-21.5%
2014 FY	25.2 Billion USD	-10.99%
2014 Q4	6.58 Billion USD	7.28%
2014 Q3	6.14 Billion USD	-3.87%
2013 Q3	6.97 Billion USD	0.33%
2013 FY	28.31 Billion USD	3.73%
2013 Q2	6.95 Billion USD	3.73%
2013 Q1	6.7 Billion USD	-10.61%
2013 Q4	7.67 Billion USD	10.05%
2012 FY	27.29 Billion USD	-7.14%
2012 Q1	6.61 Billion USD	-22.74%
2012 Q4	7.5 Billion USD	16.51%
2012 Q3	6.43 Billion USD	-4.54%
2012 Q2	6.74 Billion USD	1.95%
2011 Q3	7.29 Billion USD	1.57%
2011 FY	29.39 Billion USD	15.06%
2011 Q2	7.18 Billion USD	13.0%
2011 Q1	6.35 Billion USD	-14.95%
2011 Q4	8.56 Billion USD	17.35%
2010 Q1	5.74 Billion USD	-15.96%
2010 FY	25.54 Billion USD	11.35%
2010 Q4	7.47 Billion USD	13.73%
2010 Q3	6.57 Billion USD	14.2%
2010 Q2	5.75 Billion USD	0.09%
2009 Q1	4.99 Billion USD	-14.4%
2009 FY	22.94 Billion USD	3.43%
2009 Q4	6.84 Billion USD	23.19%
2009 Q3	5.55 Billion USD	-0.02%
2009 Q2	5.55 Billion USD	11.21%
2008 Q4	5.83 Billion USD	2.82%
2008 FY	22.18 Billion USD	4.95%
2008 Q3	5.67 Billion USD	1.45%
2008 Q2	5.59 Billion USD	10.1%
2008 Q1	5.08 Billion USD	-25.85%
2007 FY	21.13 Billion USD	14.23%
2007 Q1	4.66 Billion USD	-10.37%
2007 Q2	4.85 Billion USD	4.11%
2007 Q3	4.74 Billion USD	-2.39%
2007 Q4	6.85 Billion USD	44.47%
2006 Q4	5.2 Billion USD	10.44%
2006 Q2	4.7 Billion USD	21.16%
2006 Q1	3.88 Billion USD	-18.28%
2006 Q3	4.71 Billion USD	0.28%
2006 FY	18.5 Billion USD	10.43%
2005 Q1	3.8 Billion USD	-8.51%
2005 Q3	4.15 Billion USD	2.6%
2005 Q2	4.04 Billion USD	6.25%
2005 Q4	4.74 Billion USD	14.38%
2005 FY	16.75 Billion USD	11.07%
2004 Q4	4.16 Billion USD	11.67%
2004 Q2	3.58 Billion USD	-0.67%
2004 Q3	3.72 Billion USD	3.96%
2004 Q1	3.6 Billion USD	2.65%
2004 FY	15.08 Billion USD	15.3%
2003 Q4	3.51 Billion USD	8.49%
2003 FY	13.08 Billion USD	8.32%
2003 Q2	3.31 Billion USD	10.31%
2003 Q1	3 Billion USD	-27.66%
2003 Q3	3.24 Billion USD	-2.29%
2002 Q4	4.15 Billion USD	59.52%
2002 Q3	2.6 Billion USD	-8.85%
2002 Q2	2.85 Billion USD	0.0%
2002 Q1	- USD	100.0%
2002 FY	12.07 Billion USD	18.58%
2001 Q2	2.28 Billion USD	0.0%
2001 Q1	- USD	100.0%
2001 Q4	-14.94 Billion USD	0.0%
2001 FY	10.18 Billion USD	-5.54%
2001 Q3	- USD	-100.0%
2000 Q4	-17.02 Billion USD	0.0%
2000 Q2	2.95 Billion USD	0.0%
2000 Q3	- USD	-100.0%
2000 Q1	- USD	0.0%
2000 FY	10.78 Billion USD	1.99%
1999 FY	10.57 Billion USD	1.76%
1998 FY	10.38 Billion USD	0.0%

Peer Operating Expenses Comparison of Novartis AG

Name	Operating Expenses	Operating Expenses Difference
Roche Holding AG	28.68 Billion CHF	14.884%
Roche Holding AG	28.68 Billion CHF	14.884%

Global Stocks Search

Novartis AG (NOVN.SW)

Operating Expenses Summary of Novartis AG

Annual Operating Expenses Chart of Novartis AG (2023 - 1998)

Historical Annual Operating Expenses of Novartis AG (2023 - 1998)

Peer Operating Expenses Comparison of Novartis AG